Drug
Anagrelide
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Platelet Count Increased | 102 | 144.7 | 158.9 | signal |
| 2 | Splenomegaly | 27 | 42.5 | 43.5 | signal |
| 3 | Blood Potassium Increased | 15 | 17.0 | 17.2 | signal |
| 4 | Blood Count Abnormal | 14 | 16.8 | 17.0 | signal |
| 5 | Haematocrit Decreased | 18 | 16.6 | 16.8 | signal |
| 6 | Skin Ulcer | 23 | 16.4 | 16.7 | signal |
| 7 | Increased Tendency To Bruise | 8 | 16.0 | 16.1 | signal |
| 8 | White Blood Cell Count Increased | 30 | 14.3 | 14.7 | signal |
| 9 | Renal Tubular Necrosis | 7 | 13.1 | 13.2 | signal |
| 10 | Haemoglobin Decreased | 73 | 13.1 | 13.9 | signal |
| 11 | Acute Myocardial Infarction | 20 | 12.4 | 12.6 | signal |
| 12 | Full Blood Count Abnormal | 7 | 12.2 | 12.3 | signal |
| 13 | Red Blood Cell Count Decreased | 18 | 11.6 | 11.7 | signal |
| 14 | Cardiomyopathy | 9 | 11.2 | 11.3 | signal |
| 15 | Pneumocystis Jirovecii Pneumonia | 6 | 11.0 | 11.1 | signal |
| 16 | Blood Iron Decreased | 7 | 10.9 | 11.0 | signal |
| 17 | Urosepsis | 5 | 10.0 | 10.0 | signal |
| 18 | Cytomegalovirus Infection | 9 | 10.0 | 10.0 | signal |
| 19 | Hypertensive Crisis | 6 | 9.9 | 9.9 | signal |
| 20 | Myocardial Ischaemia | 6 | 9.6 | 9.7 | signal |
| 21 | Haemoptysis | 14 | 9.2 | 9.3 | signal |
| 22 | Decreased Activity | 5 | 8.6 | 8.6 | signal |
| 23 | Orthostatic Hypotension | 8 | 8.4 | 8.5 | signal |
| 24 | Ejection Fraction Decreased | 7 | 8.3 | 8.3 | signal |
| 25 | Transient Ischaemic Attack | 15 | 8.1 | 8.2 | signal |
| 26 | Post Procedural Haemorrhage | 5 | 7.9 | 7.9 | signal |
| 27 | Sedation | 11 | 7.8 | 7.8 | signal |
| 28 | Skin Cancer | 9 | 7.7 | 7.7 | signal |
| 29 | Skin Haemorrhage | 6 | 7.7 | 7.7 | signal |
| 30 | Impaired Healing | 13 | 7.3 | 7.4 | signal |
| 31 | Drug Resistance | 10 | 7.2 | 7.2 | signal |
| 32 | Product Prescribing Error | 9 | 7.0 | 7.0 | signal |
| 33 | Product Availability Issue | 8 | 6.6 | 6.6 | signal |
| 34 | Basal Cell Carcinoma | 5 | 5.9 | 5.9 | signal |
| 35 | Thrombotic Microangiopathy | 3 | 5.7 | 5.7 | signal |
| 36 | Full Blood Count Decreased | 6 | 5.5 | 5.5 | signal |
| 37 | Inappropriate Antidiuretic Hormone Secretion | 3 | 5.4 | 5.4 | signal |
| 38 | Fluid Overload | 4 | 5.0 | 5.0 | signal |
| 39 | Cytopenia | 3 | 4.6 | 4.6 | signal |
| 40 | Metrorrhagia | 4 | 4.3 | 4.3 | signal |
| 41 | Product Dose Omission | 15 | 4.2 | 4.2 | signal |
| 42 | Pulmonary Arterial Hypertension | 3 | 3.8 | 3.8 | no signal |
| 43 | Drug Dose Omission | 28 | 3.1 | 3.1 | signal |
| 44 | Suicide Attempt | 9 | 2.7 | 2.7 | signal |
| 45 | Intentional Overdose | 7 | 2.0 | 2.0 | no signal |